Trial intelligence / Profile preview

Pharmacokinetics and Pharmacodynamics of Sertraline After Low Dose Administration

KCT0000022Phase 4Completed

Sponsor
Korea Health Industry Development Institute
Start
Jul 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of sertraline in major depressive disorder (MDD), sponsored by Korea Health Industry Development Institute. Started Jul 2009; status: completed.

02

Drugs

sertraline
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on KCT0000022.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0000022.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call